About Embody
Embody is a Healthcare company based in Norfolk (United States) founded in 2014 by Michael Francis, and was acquired by Zimmer Biomet in January 2023. It operates as a collagen-based regenerative matrices for soft tissue repair are provided. Embody has raised $41.4 million across 14 funding rounds from investors including HHS, DARPA and Zimmer Biomet. The company has 25 employees. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is Embody, Inc. Its competitors include Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical and 5 more; 10 of its 10 listed competitors have raised funding.
Company details
Founded in 2014 and based in Norfolk, United States, collagen-based regenerative matrices for soft tissue repair are developed by the company. Manufacturing platforms incorporating electrospinning and microfluidics are utilized in operations. Applications include drug delivery and wound healing, with products such as the Tapestry biointegrative Implant, Microbraid collagen suture, and Microbrace offered in the regenerative medicine sector.
- Headquarters Norfolk, United States
- Employees 25
- Founders Michael Francis
- Stage Acquired
- SectorsHealthcare
- Website embody-inc.com
- Social LinkedIn
- Acquired by Zimmer Biomet (Jan 2023)
- Legal Name Embody, Inc.
- Total Equity Funding$41.4M (USD)
in 14 rounds
- Latest Funding Round$10.4M (USD), Series C
Sep 2022
- InvestorsHHS
& 8 more
- Employee Count25
- Acquired byZimmer Biomet
(Jan 2023)
Funding Insights of Embody
Embody has successfully raised a total of $41.4M across 14 strategic funding rounds. The most recent funding activity was a Series C round of $10.4 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $41.4M
- Total Rounds 14
- Last Round Series C — $10.4M
- First Round $150,000
(Jan 2017)
- Investors Count 8
Latest 10 of 14 funding rounds of Embody with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | $10.4M | Series C | – | cultivate(MD) | – |
| Aug 2021 | – | Debt – Conventional | – | – | |
| Jul 2021 | $11.5M | Series B | – | Horizon | – |
| Apr 2020 | $9.3M | Series A | – | – | |
| Jan 2020 | $2.5M | Grant | – | – | |
| Sep 2019 | $223,907 | Grant | – | – | |
| Jul 2019 | $914,084 | Grant | – | – | |
| Mar 2019 | $3.6M | Series A | – | cultivate(MD) | – |
| Mar 2019 | $3.6M | Series A | – | – | – |
| Aug 2018 | $1.5M | Seed | – | 757 Angels, Center for Innovative Technology | – |
9 investors in total: 9 institutional.
Investors in Embody
Embody has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, DARPA and Zimmer Biomet.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital funding for medical device companies is provided. | 2017 | cultivate-md.com | Grand Rapids, United States | |
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Early-stage VC firm funding companies in the US | – | cit.org | Herndon, United States | |
High-growth startups in Virginia are funded by 757 Angels. | – | 757angelsgroup.com | Norfolk, United States | |
- | 1958 | darpa.mil | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Virginia Catalyst is focused on life sciences funding initiatives. | – | virginiacatalyst.org | Richmond, United States | |
- | – | norfolkdevelopment.com | - | |
Medical devices for multiple health purposes are manufactured. | 1927 | zimmerbiomet.com | Warsaw, United States |
Investor details for Embody
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Embody
10 people are tracked at Embody (6 in leadership, 4 in team); the tracked headcount is 25.
| Name | Role | Group |
|---|---|---|
Michael Francis | Co-Founder | Leadership |
Patrice N. Gooden | Administrative Assistant to Director of Manufacturing & Logistics | Leadership |
Tom Dula | Chief Financial Officer | Leadership |
John (JP) Patane MBA | Eastern U.S. Director of Sales Embody Biologics Inc | Leadership |
Steven South | Director of Finance | Leadership |
Christine Nelson | Vice President of Manufacturing & Logistics | Leadership |
Victoria Stagnaro | Senior Research Associate | Team |
Joseph Hanson | Biologics Account Manager - EmBody | Team |
Stephen Wirth | Biologics Account Manager- Mid Atlantic | Team |
Jason Axelrod | Area Sales Manager | Team |
Complete people profiles for Embody
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Embody
4 dated milestones of Embody across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Embody is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series C, of $10.4M.
- Exit Acquired by Zimmer Biomet.
Competitors of Embody
Embody has 10 listed competitors in our database, 10 of them funded. They include Miach Orthopaedics, Collplant, Nanochon, GeniPhys and Nurami Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| miachortho.com | 2016 | Boston, United States | $72.5M | – | Bio-engineered surgical implants for connective tissue repair are developed. | |
| collplant.com | 2004 | Ness Ziona, Israel | $16.3M | – | Plant-derived collagen is developed for tissue repair and 3D bioprinting. | |
| nanochon.com | 2016 | Burke, United States | $6M | – | 3D-printed implants are developed for treating joint injuries. | |
| geniphys.com | 2014 | Zionsville, United States | $10.47M | – | Collagen polymers are developed for tissue regeneration applications. | |
| nurami-medical.com | 2014 | Nazareth, Israel | $37.45M | – | Nanofiber and sealant technology for soft tissue repair is developed. | |
| rotationmedical.com | 2009 | Minneapolis, United States | $54.58M | 34 | A rotator cuff repair system is developed for disease treatment. | |
| jellatech.com | 2020 | Morrisville, United States | $5.5M | 8 | Provider of animal-free collagen and gelatin products for multiple industries | |
| orthogenrx.com | 2012 | Doylestown, United States | $1.19M | 1,522 | Generic Class III medical devices in orthopedics are developed. | |
| inovedis.com | 2019 | Eden Prairie, United States | $4M | – | Developer of surgical implants for tendon healing | |
| cayennemedical.com | 2005 | Phoenix, United States | $46.3M | 54 | Soft tissue reconstruction solutions for knee and shoulder |
Detailed competitors of Embody
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Embody
The website of Embody (embody-inc.com) receives about 3.8K visits a month.
- Monthly visits3.8K
▲ 69.3% vs previous month
Top companies in Orthopedics
10 companies that operate in the same segment as Embody (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | 4,125 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608.25 M | – | 197 | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Embody
Complete news archive for Embody
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Embody
Embody was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Embody is headquartered in Norfolk, United States. It is registered at Norfolk, Virginia, United States.
Embody is a funded company, having raised a total of $41.4M across 14 funding rounds to date. The company's 1st funding round was a Seed of $1.5M, raised on Jan 2017.
Embody has 25 employees.
Founded in 2014 and based in Norfolk, United States, collagen-based regenerative matrices for soft tissue repair are developed by the company. Manufacturing platforms incorporating electrospinning and microfluidics are utilized in operations. Applications include drug delivery and wound healing, with products such as the Tapestry biointegrative Implant, Microbraid collagen suture, and Microbrace offered in the regenerative medicine sector.
Embody's top competitors include Miach Orthopaedics, Collplant and Jellatech.
Embody has 9 investors. Key investors include HHS, DARPA, Zimmer Biomet, Horizon Tech Finance, and cultivate(MD).
Embody operates through Embody, Inc..
Yes. Embody was acquired by Zimmer Biomet in January 2023.